Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Huiying
Contact Huiying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Sufficient-dose Brentuximab vedotin improves prognosis in patients with classic Hodgkin lymphoma: a single-center real-world study in China
Abstract Background: Classic Hodgkin lymphoma (cHL) is highly curable for most patients with cytotoxic chemotherapy, while targeted agents such as brentuximab vedotin (BV) have been incorporated into frontline regimens. This single-center retrospective study aimed to compare the efficacy and safety of a local ABVD-like regimen and a BV-containing A-AVD-like regimen in Chinese patients with cHL. Methods: A total of 243 cHL patients were enrolled, including 192 in ABVD and 51 in A-AVD.
In Situ Carbon‐Coated Na2CO3@C as a High‐Capacity Sacrificial Additive: Enhancing Presodiation Efficiency via Defect‐Driven Electron Transfer
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Huiying
Contact Huiying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack